Tysabri and Weakness - a phase IV clinical study of FDA data
Summary:
Weakness is found among people who take Tysabri, especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Tysabri and have Weakness. It is created by eHealthMe based on reports of 210,327 people who have side effects when taking Tysabri from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
210,327 people reported to have side effects when taking Tysabri.
Among them, 14,800 people (7.04%) have Weakness.
What is Tysabri?
Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 210,824 Tysabri users for its effectiveness, alternative drugs and more.
What is Weakness?
Weakness is found to be associated with 5,289 drugs and 6,294 conditions by eHealthMe.
Number of Tysabri and Weakness reports submitted per year:
Time on Tysabri when people have Weakness *:
Gender of people who have Weakness when taking Tysabri*:
Age of people who have Weakness when taking Tysabri *:
Common drugs people take besides Tysabri *:
Common side effects people have besides Weakness *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tysabri and have Weakness?
Check whether Weakness is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Weakness and when was it recovered:
Expand to all the drugs that have ingredients of natalizumab:
- Weakness and drugs with ingredients of natalizumab (14,867 reports)
Alternative drugs to, pros and cons of Tysabri:
- Tysabri (210,824 reports)
Common Tysabri side effects:
- Fatigue (feeling of tiredness): 23,185 reports
- Weakness: 14,800 reports
- Headache (pain in head): 11,871 reports
- Memory loss: 11,095 reports
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11,021 reports
- Urinary tract infection: 9,886 reports
Browse all side effects of Tysabri:
a b c d e f g h i j k l m n o p q r s t u v w x y zWeakness treatments and more:
- Weakness (513,351 reports)
COVID vaccines that are related to Weakness:
- Weakness in Moderna COVID Vaccine
- Weakness in Pfizer BioNTech Covid Vaccine
- Weakness in Johnson and Johnson Covid Vaccine
Common drugs associated with Weakness:
- Prednisone: 26,970 reports
- Aspirin: 26,881 reports
- Humira: 16,920 reports
- Methotrexate: 16,130 reports
- Metformin: 15,821 reports
- Omeprazole: 15,424 reports
- Tysabri: 14,800 reports
- Lisinopril: 14,469 reports
- Lipitor: 14,239 reports
- Synthroid: 13,523 reports
All the drugs that are associated with Weakness:
- Weakness (5,289 drugs)
Common conditions associated with Weakness:
- Multiple sclerosis: 44,040 reports
- High blood pressure: 24,528 reports
- Rheumatoid arthritis: 22,785 reports
- High blood cholesterol: 17,735 reports
- Pain: 15,184 reports
All the conditions that are associated with Weakness:
- Weakness (6,294 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on natalizumab (the active ingredients of Tysabri) and Tysabri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- How effective is Nitroglycerin for Chest Pain? - a second ago
- Repatha and Sleep Talking - 2 seconds ago
- How effective is Lamictal for Bipolar Mania? - 3 seconds ago
- How effective is Metoprolol Tartrate for Chest Pain? - 12 seconds ago
- How effective is Amlodipine Maleate; Benazepril Hydrochloride for Blood Pressure Management? - 13 seconds ago
- How effective is Perindopril Erbumine for Blood Pressure Management? - 17 seconds ago
- Dysuria Aggravated and Neonatal Respiratory Failure - 21 seconds ago
- Wellbutrin and Weight Gain Poor - 23 seconds ago
- Flexeril and Ruptured Cerebral Aneurysm - 25 seconds ago
- Metrogel-Vaginal and Proair Hfa drug interaction - 25 seconds ago